TAXES ON INCOME (Schedule of Deferred Tax Assets) (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
In respect of:
Research and development expenses	$ 4,625	$ 6,568
Other timing differences	(1,387)	(2,115)
Net operating loss carry forwards	51,472	54,097
Valuation allowance	(51,618)	(58,550)	$ (61,520)
Total net deferred tax assets	$ 3,092	$ 0